Publications by authors named "E Volant"

Claim this Profile
P
PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort.
F Cherifi, L Cabel, C Bousrih, E Volant, F Dalenc

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
F Poumeaud, M Morisseau, L Cabel, A Gonçalves, C Rivier, E Volant

Br J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.
Jean-Sebastien Frenel, Jean Zeghondy, Catherine Guérin-Charbonnel, Audrey Mailliez, Elsa Volant

JAMA Netw Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on the working paper: evaluative criteria for Catholic health care facilities.
E Volant

Cathol Hosp· February 1980

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis